Sodium-wasting nephropathy caused by cisplatin in esophageal cancer

Journal of Supportive Oncology

Volumn 6, Issue 7, 2008, Pages 305-306

  Abdelghani, Loui ^a   Modha, Kunjam ^a   Albaddawi, Eman ^a   Subramanian, Seshan ^a  

^a MERCY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CISPLATIN; FLUOROURACIL; METFORMIN; PACLITAXEL; PHENYTOIN; SODIUM CHLORIDE;

ADULT; CANCER PALLIATIVE THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DECREASED APPETITE; DIABETES MELLITUS; DRUG INDUCED DISEASE; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS ULCER; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOMAGNESEMIA; HYPONATREMIA; LETTER; LUNG METASTASIS; LUNG NODULE; MALE; NATRIURESIS; SALT LOSING NEPHRITIS; SEIZURE; SERUM OSMOLALITY; THORAX PAIN; URINE OSMOLALITY; WATER DEPRIVATION; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; HUMANS; HYPONATREMIA; KIDNEY DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NATRIURESIS; SODIUM;

EID: 53549094394     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (17)

1. Peyrade F, Taillan B, Lebrun C, Bendini JC, Passerron C, Dujardin P. Hyponatremia during treatment with cisplatin [in French]. Presse Med 1997;26:1523-1525. [9435831]
2. Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer 1996;4:341-350. [8883227]
3. Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer 1996;4:341-350. [8883227]
4. Orbo A, Simonsen E. Cisplatin-induced sodium and magnesium wastage. Eur J Cancer 1992;28A:1294. [1627398]
5. Lammers PJ, White L, Ettinger LJ. Cis-platinum-induced renal sodium wasting. Med Pediatr Oncol 1984;12:343-346. [6541750]
6. Cao L, Joshi P, Sumoza D. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: case report. am J Clin Oncol 2002;25:344-346. [12151962]
7. DeFronzo RA, Thier SO. Pathophysiologic approach to hyponatremia. Arch Intern Med 1980; 140:897-902. [7387296]
8. Kufe DW, Pollock RE, Weichselbaum RR, et al, eds. Cancer Medicine. 6th ed. Hamilton, Ontario, Canada: BC Decker Inc; 2003.
9. Iida T, Makino Y, Okamoto K, et al. Functional modulation of the mineralocorticoid receptor by cis-diamminedichloroplatinum (11). Kidney Int 2000;58:1450-1460. [11012880]
10. Hutchison FN, Perez EA, Gandara DR, Lawrence HJ, Kaysen GA. Renal salt wasting in patients treated with cisplatin. Ann Intern Med 1988;108:21-25. [3337511]
11. Bosl GJ, Leitner SP, Atlas SA, Sealey JE, Preibisz JJ, Scheiner E.Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors. J Clin Oncol 1986;4:1684-1689. [3021923]
12. Kurt E, Manavoglu O, Dilek K, Orhan B, Evrensel T. Effect of cisplatin on plasma renin activity and serum aldosterone levels. Clin Nephrol 1999;52:397-398. [10604651]
13. University of California at Los Angeles Division of Endocrinology, Diabetes and Hypertension. Syndrome of inappropriate ADH. Available at: http://www.endocrinology.med.ucla.edu/siadh.htm. Accessed June 23, 2008.
14. Kurtzberg J, Dennis VW, Kinney TR. Cisplatinum-induced renal salt wasting. Med Pediatr Oncol 1984;12:150-154. [6538257]
15. Vassal G, Rubie H, Kalifa C, Hartmann O, Lemerle J. Hyponatremia and renal sodium wasting in patients receiving cisplatinum. Pediatric Hematol Oncol 1987;4:337-344. [3152940]
16. el Weshi A, Thieblemont C, Cottin V, Barbet N, Catimel G. Cisplatin-induced hyponatremia and renal sodium wasting. Acta Oncol 1995;34:264-265. [7718269]
17. Cao L, Joshi P, Sumoza D. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: case report. Am J Clin Oncol 2002;25:344-346. [12151962]